Thromboxane A2 Receptor Blocking Peptide (#BLP-PR069) is the original antigen used for immunization during Anti-Thromboxane A2 Receptor Antibody (#APR-069) generation. The blocking peptide binds and ‘blocks’ Anti-Thromboxane A2 Receptor primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.